Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Under Armour Inc Class A (UA) Price & Performance

Abeona Therapeutics IncTrade
Under Armour Inc Class ATrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Under Armour Inc Class A — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Under Armour Inc Class A is far larger — about 5.4× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.

ABEOUA
Market Cap
$421.19M$2.26B
Sector
HealthConsumer Cyclical
52-Week High
$7.45$7.88
52-Week Low
$4.17$3.96
Enterprise Value
$276.10M$3.24B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Under Armour Inc Class A

Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.

Read more on UA